Literature DB >> 17378256

Fatal anaphylaxis: postmortem findings and associated comorbid diseases.

Paul A Greenberger1, Brian D Rotskoff, Barry Lifschultz.   

Abstract

BACKGROUND: Anaphylaxis is an infrequent cause of sudden death. Death often results from circulatory collapse, respiratory arrest, or both.
OBJECTIVE: To investigate the causes of death, anatomical findings, and comorbid diseases in cases of fatal anaphylaxis.
METHODS: This is a retrospective case review of 25 unselected cases of documented fatal anaphylaxis. Each case report contained details of the fatal reaction, a review of the medical record, and laboratory and autopsy findings. Serum tryptase concentrations were measured in 7 cases.
RESULTS: The anaphylactic deaths included 7 reactions to medications, 6 to radiocontrast material, 6 to Hymenoptera stings, and 4 to foods. The mean age was 59 years. The anaphylactic reaction began within 30 minutes of exposure in 21 of 25 cases, with death occurring within 60 minutes in 13 of 25 cases. Urticaria occurred in only 1 of 25 cases. Anatomical findings consistent with anaphylaxis were present in 18 of 23 patients undergoing autopsy. At least 1 significant comorbid disease was identified in 22 of 25 cases.
CONCLUSIONS: (1) Elderly patients with substantial comorbid conditions constituted a significant number of the anaphylactic fatalities; (2) the onset of severe anaphylaxis occurred in less than 30 minutes in nearly every case; (3) 18 of 23 cases were associated with specific anatomical findings of anaphylaxis; (4) self-administered epinephrine was used in just 1 of 5 cases; and (5) serum total tryptase concentrations were elevated markedly in 4 of 7 cases tested.

Entities:  

Mesh:

Year:  2007        PMID: 17378256     DOI: 10.1016/S1081-1206(10)60714-4

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  34 in total

Review 1.  Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.

Authors:  James L Kuhlen; Yamini V Virkud
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

Review 2.  Kounis syndrome (allergic acute coronary syndrome): different views in allergologic and cardiologic literature.

Authors:  Filippo Fassio; Fabio Almerigogna
Journal:  Intern Emerg Med       Date:  2012-01-22       Impact factor: 3.397

3.  Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.

Authors:  Joshua A Boyce; Amal Assa'ad; A Wesley Burks; Stacie M Jones; Hugh A Sampson; Robert A Wood; Marshall Plaut; Susan F Cooper; Matthew J Fenton; S Hasan Arshad; Sami L Bahna; Lisa A Beck; Carol Byrd-Bredbenner; Carlos A Camargo; Lawrence Eichenfield; Glenn T Furuta; Jon M Hanifin; Carol Jones; Monica Kraft; Bruce D Levy; Phil Lieberman; Stefano Luccioli; Kathleen M McCall; Lynda C Schneider; Ronald A Simon; F Estelle R Simons; Stephen J Teach; Barbara P Yawn; Julie M Schwaninger
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

Review 4.  Glucocorticoids for the treatment of anaphylaxis.

Authors:  Karen Jui Lin Choo; F Estelle R Simons; Aziz Sheikh
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 5.  Particularities of allergy in the Tropics.

Authors:  Luis Caraballo; Josefina Zakzuk; Bee Wah Lee; Nathalie Acevedo; Jian Yi Soh; Mario Sánchez-Borges; Elham Hossny; Elizabeth García; Nelson Rosario; Ignacio Ansotegui; Leonardo Puerta; Jorge Sánchez; Victoria Cardona
Journal:  World Allergy Organ J       Date:  2016-06-27       Impact factor: 4.084

6.  A multifaceted intervention for patients with anaphylaxis increases epinephrine use in adult emergency department.

Authors:  Veena Manivannan; Erik P Hess; Venkatesh R Bellamkonda; David M Nestler; M Fernanda Bellolio; John B Hagan; Kharmene L Sunga; Wyatt W Decker; James T C Li; Lori N Scanlan-Hanson; Samuel C Vukov; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2014-02-16

Review 7.  Anaphylaxis caused by intravenous fluorescein: clinical characteristics and review of literature.

Authors:  Sang Ook Ha; Dae Yong Kim; Chang Hwan Sohn; Kyoung Soo Lim
Journal:  Intern Emerg Med       Date:  2013-11-30       Impact factor: 3.397

Review 8.  Mast cells in human and experimental cardiometabolic diseases.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

Review 9.  Safety of epinephrine for anaphylaxis in the emergency setting.

Authors:  Joseph P Wood; Stephen J Traub; Christopher Lipinski
Journal:  World J Emerg Med       Date:  2013

Review 10.  Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.

Authors:  Aziz Sheikh; F Estelle R Simons; Victoria Barbour; Allison Worth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.